Policy Makers' Priorities for Addressing Youth Substance Use and Factors That Influence Priorities.


Journal

Psychiatric services (Washington, D.C.)
ISSN: 1557-9700
Titre abrégé: Psychiatr Serv
Pays: United States
ID NLM: 9502838

Informations de publication

Date de publication:
01 04 2022
Historique:
pubmed: 14 8 2021
medline: 5 4 2022
entrez: 13 8 2021
Statut: ppublish

Résumé

Understanding public policy makers' priorities for addressing youth substance use and the factors that influence these priorities can inform the dissemination and implementation of strategies that promote evidence-based decision making. This study characterized the priorities of policy makers in substance use agencies of U.S. states and counties for addressing youth substance use, the factors that influenced these priorities, and the differences in priorities and influences between state and county policy makers. In 2020, a total of 122 substance use agency policy makers from 35 states completed a Web-based survey (response rate=22%). Respondents rated the priority of 14 issues related to youth substance use and the extent to which nine factors influenced these priorities. Data were analyzed as dichotomous and continuous variables and for state and county policy makers together and separately. The highest priorities for youth substance use were social determinants of substance use (87%), adverse childhood experiences and childhood trauma (85%), and increasing access to school-based substance use programs (82%). The lowest priorities were increasing access to naloxone for youths (49%), increasing access to medications for opioid use disorder among youths (49%), and deimplementing non-evidence-based youth substance use programs (41%). The factors that most influenced priorities were budget issues (80%) and state legislature (69%), federal (67%), and governor priorities (65%). Issues related to program implementation and deimplementation were significantly higher priorities for state than for county policy makers. These findings can inform the tailoring of dissemination and implementation strategies to account for the inner- and outer-setting contexts of substance use agencies.

Identifiants

pubmed: 34384231
doi: 10.1176/appi.ps.202000919
pmc: PMC9704547
mid: NIHMS1783164
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

388-395

Subventions

Organisme : NIMH NIH HHS
ID : P50 MH113662
Pays : United States

Références

Am Psychol. 2020 Nov;75(8):1052-1066
pubmed: 33252944
Psychiatr Serv. 2020 Nov 1;71(11):1170-1178
pubmed: 32517640
Implement Sci. 2015 Apr 21;10:53
pubmed: 25895742
Am J Community Psychol. 2018 Sep;62(1-2):189-202
pubmed: 29971792
Subst Abuse Treat Prev Policy. 2019 Mar 4;14(1):12
pubmed: 30832690
J Am Acad Child Adolesc Psychiatry. 2001 Apr;40(4):419-26
pubmed: 11314567
Pharmacoeconomics. 2016 Sep;34(9):863-87
pubmed: 27002518
J Subst Abuse Treat. 2008 Apr;34(3):272-81
pubmed: 17600651
Pediatrics. 2020 Oct;146(4):
pubmed: 32928988
Pediatrics. 2019 Feb;143(2):
pubmed: 30602544
Public Health Rep. 2002;117 Suppl 1:S135-45
pubmed: 12435837
Implement Sci. 2014 Jan 08;9:1
pubmed: 24398253
J Subst Abuse Treat. 2013 Jan;44(1):1-3
pubmed: 23083972
Implement Sci. 2019 Jan 5;14(1):1
pubmed: 30611302
JAMA Netw Open. 2018 Dec 7;1(8):e186558
pubmed: 30646334
Public Health Rep. 2021 Mar-Apr;136(2):161-171
pubmed: 33108978
Psychol Addict Behav. 2011 Jun;25(2):194-205
pubmed: 21443291
JAMA Pediatr. 2017 Aug 1;171(8):729-731
pubmed: 28628699
Pediatrics. 2016 Sep;138(3):
pubmed: 27550978
Child Youth Serv Rev. 2014 Apr 1;39:177-182
pubmed: 24729650
Int J Drug Policy. 2020 Aug;82:102792
pubmed: 32540516
J Adolesc Health. 2019 Nov;65(5):571-572
pubmed: 31648752
Psychiatr Serv. 2016 Dec 1;67(12):1355-1361
pubmed: 27364817
J Adolesc Health. 2019 Nov;65(5):698-701
pubmed: 31540779
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Adm Policy Ment Health. 2011 Jan;38(1):4-23
pubmed: 21197565
JAMA Pediatr. 2017 Aug 1;171(8):747-755
pubmed: 28628701
Implement Sci. 2020 Jan 9;15(1):2
pubmed: 31915032
Annu Rev Public Health. 2020 Apr 2;41:201-221
pubmed: 31905323
Implement Sci. 2018 Sep 19;13(1):121
pubmed: 30231934
J Subst Abuse Treat. 2006 Jul;31(1):25-39
pubmed: 16814008
Am Psychol. 2020 Nov;75(8):1130-1145
pubmed: 33252950
Health Aff (Millwood). 2013 Nov;32(11):2005-12
pubmed: 24191093
Psychiatr Serv. 2018 Oct 1;69(10):1105-1108
pubmed: 29983112
Implement Sci. 2008 May 16;3:26
pubmed: 18485219
J Gen Intern Med. 2021 Nov;36(11):3373-3382
pubmed: 33782896
J Behav Health Serv Res. 2017 Apr;44(2):177-194
pubmed: 26289563
Implement Sci. 2014 Dec 18;9:168
pubmed: 25518730
Adm Policy Ment Health. 2020 Sep;47(5):779-787
pubmed: 31828555
Adm Policy Ment Health. 2017 Mar;44(2):160-163
pubmed: 27418342

Auteurs

Jonathan Purtle (J)

Department of Health Management and Policy, Drexel University Dornsife School of Public Health, Philadelphia (Purtle, Nelson, Henson); Department of Child and Adolescent Psychiatry, New York University School of Medicine, New York City (Horwitz, Hoagwood); Brown School at Washington University in St. Louis, St. Louis (McKay).

Katherine L Nelson (KL)

Department of Health Management and Policy, Drexel University Dornsife School of Public Health, Philadelphia (Purtle, Nelson, Henson); Department of Child and Adolescent Psychiatry, New York University School of Medicine, New York City (Horwitz, Hoagwood); Brown School at Washington University in St. Louis, St. Louis (McKay).

Rosie Mae Henson (RM)

Department of Health Management and Policy, Drexel University Dornsife School of Public Health, Philadelphia (Purtle, Nelson, Henson); Department of Child and Adolescent Psychiatry, New York University School of Medicine, New York City (Horwitz, Hoagwood); Brown School at Washington University in St. Louis, St. Louis (McKay).

Sarah McCue Horwitz (SM)

Department of Health Management and Policy, Drexel University Dornsife School of Public Health, Philadelphia (Purtle, Nelson, Henson); Department of Child and Adolescent Psychiatry, New York University School of Medicine, New York City (Horwitz, Hoagwood); Brown School at Washington University in St. Louis, St. Louis (McKay).

Mary M McKay (MM)

Department of Health Management and Policy, Drexel University Dornsife School of Public Health, Philadelphia (Purtle, Nelson, Henson); Department of Child and Adolescent Psychiatry, New York University School of Medicine, New York City (Horwitz, Hoagwood); Brown School at Washington University in St. Louis, St. Louis (McKay).

Kimberly E Hoagwood (KE)

Department of Health Management and Policy, Drexel University Dornsife School of Public Health, Philadelphia (Purtle, Nelson, Henson); Department of Child and Adolescent Psychiatry, New York University School of Medicine, New York City (Horwitz, Hoagwood); Brown School at Washington University in St. Louis, St. Louis (McKay).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH